177 related articles for article (PubMed ID: 36066375)
1. Leber hereditary optic neuropathy: new and emerging therapies.
Davila-Siliezar P; Carter M; Milea D; Lee AG
Curr Opin Ophthalmol; 2022 Nov; 33(6):574-578. PubMed ID: 36066375
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy Treated within 6 Months of Disease Onset.
Newman NJ; Yu-Wai-Man P; Carelli V; Moster ML; Biousse V; Vignal-Clermont C; Sergott RC; Klopstock T; Sadun AA; Barboni P; DeBusk AA; Girmens JF; Rudolph G; Karanjia R; Taiel M; Blouin L; Smits G; Katz B; Sahel JA;
Ophthalmology; 2021 May; 128(5):649-660. PubMed ID: 33451738
[TBL] [Abstract][Full Text] [Related]
3. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.
Mashima Y; Kigasawa K; Shinoda K; Wakakura M; Oguchi Y
BMC Ophthalmol; 2017 Oct; 17(1):192. PubMed ID: 29047345
[TBL] [Abstract][Full Text] [Related]
4. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
Pemp B; Kircher K; Reitner A
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
[TBL] [Abstract][Full Text] [Related]
5. Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy.
Shamsnajafabadi H; MacLaren RE; Cehajic-Kapetanovic J
Cells; 2023 Aug; 12(15):. PubMed ID: 37566092
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Follow-Up After Unilateral Intravitreal Gene Therapy for Leber Hereditary Optic Neuropathy: The RESTORE Study.
Biousse V; Newman NJ; Yu-Wai-Man P; Carelli V; Moster ML; Vignal-Clermont C; Klopstock T; Sadun AA; Sergott RC; Hage R; Esposti S; La Morgia C; Priglinger C; Karanja R; Blouin L; Taiel M; Sahel JA;
J Neuroophthalmol; 2021 Sep; 41(3):309-315. PubMed ID: 34415265
[TBL] [Abstract][Full Text] [Related]
7. Long-term outcomes of gene therapy for the treatment of Leber's hereditary optic neuropathy.
Yang S; Ma SQ; Wan X; He H; Pei H; Zhao MJ; Chen C; Wang DW; Dong XY; Yuan JJ; Li B
EBioMedicine; 2016 Aug; 10():258-68. PubMed ID: 27426279
[TBL] [Abstract][Full Text] [Related]
8. Visual Outcomes in Leber Hereditary Optic Neuropathy Patients With the m.11778G>A (MTND4) Mitochondrial DNA Mutation.
Newman NJ; Carelli V; Taiel M; Yu-Wai-Man P
J Neuroophthalmol; 2020 Dec; 40(4):547-557. PubMed ID: 32969847
[TBL] [Abstract][Full Text] [Related]
9. [Leber's Hereditary Optic Neuropathy].
Priglinger C; Klopstock T; Rudolph G; Priglinger SG
Klin Monbl Augenheilkd; 2019 Nov; 236(11):1271-1282. PubMed ID: 31639883
[TBL] [Abstract][Full Text] [Related]
10. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
Lyseng-Williamson KA
Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
[TBL] [Abstract][Full Text] [Related]
11. Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.
Lam BL; Feuer WJ; Schiffman JC; Porciatti V; Vandenbroucke R; Rosa PR; Gregori G; Guy J
JAMA Ophthalmol; 2014 Apr; 132(4):428-36. PubMed ID: 24525545
[TBL] [Abstract][Full Text] [Related]
12. Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results.
Feuer WJ; Schiffman JC; Davis JL; Porciatti V; Gonzalez P; Koilkonda RD; Yuan H; Lalwani A; Lam BL; Guy J
Ophthalmology; 2016 Mar; 123(3):558-70. PubMed ID: 26606867
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy.
Zhao X; Zhang Y; Lu L; Yang H
Curr Eye Res; 2020 Oct; 45(10):1315-1323. PubMed ID: 32111141
[No Abstract] [Full Text] [Related]
14. Developments in the Treatment of Leber Hereditary Optic Neuropathy.
Chen BS; Yu-Wai-Man P; Newman NJ
Curr Neurol Neurosci Rep; 2022 Dec; 22(12):881-892. PubMed ID: 36414808
[TBL] [Abstract][Full Text] [Related]
15. Rapid visual recovery after coenzyme q10 treatment of leber hereditary optic neuropathy.
Huang CC; Kuo HC; Chu CC; Kao LY
J Neuroophthalmol; 2002 Mar; 22(1):66. PubMed ID: 11937918
[No Abstract] [Full Text] [Related]
16. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy.
Aleo SJ; Del Dotto V; Romagnoli M; Fiorini C; Capirossi G; Peron C; Maresca A; Caporali L; Capristo M; Tropeano CV; Zanna C; Ross-Cisneros FN; Sadun AA; Pignataro MG; Giordano C; Fasano C; Cavaliere A; Porcelli AM; Tioli G; Musiani F; Catania A; Lamperti C; Marzoli SB; De Negri A; Cascavilla ML; Battista M; Barboni P; Carbonelli M; Amore G; La Morgia C; Smirnov D; Vasilescu C; Farzeen A; Blickhaeuser B; Prokisch H; Priglinger C; Livonius B; Catarino CB; Klopstock T; Tiranti V; Carelli V; Ghelli AM
Cell Rep Med; 2024 Feb; 5(2):101383. PubMed ID: 38272025
[TBL] [Abstract][Full Text] [Related]
18. Treatment strategies for Leber hereditary optic neuropathy.
Jurkute N; Harvey J; Yu-Wai-Man P
Curr Opin Neurol; 2019 Feb; 32(1):99-104. PubMed ID: 30516647
[TBL] [Abstract][Full Text] [Related]
19. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
Catarino CB; von Livonius B; Priglinger C; Banik R; Matloob S; Tamhankar MA; Castillo L; Friedburg C; Halfpenny CA; Lincoln JA; Traber GL; Acaroglu G; Black GCM; Doncel C; Fraser CL; Jakubaszko J; Landau K; Langenegger SJ; Muñoz-Negrete FJ; Newman NJ; Poulton J; Scoppettuolo E; Subramanian P; Toosy AT; Vidal M; Vincent AL; Votruba M; Zarowski M; Zermansky A; Lob F; Rudolph G; Mikazans O; Silva M; Llòria X; Metz G; Klopstock T
J Neuroophthalmol; 2020 Dec; 40(4):558-565. PubMed ID: 32991388
[TBL] [Abstract][Full Text] [Related]
20. Multilocus Mitochondrial Mutations Do Not Directly Affect the Efficacy of Gene Therapy for Leber Hereditary Optic Neuropathy.
Yang S; Chen C; Yuan JJ; Wang SS; Wan X; He H; Ma SQ; Li B
J Neuroophthalmol; 2020 Mar; 40(1):22-29. PubMed ID: 31246675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
